These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7685560)

  • 41. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14.
    Pugin J; Schürer-Maly CC; Leturcq D; Moriarty A; Ulevitch RJ; Tobias PS
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2744-8. PubMed ID: 7681988
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reconstruction of LPS Transfer Cascade Reveals Structural Determinants within LBP, CD14, and TLR4-MD2 for Efficient LPS Recognition and Transfer.
    Ryu JK; Kim SJ; Rah SH; Kang JI; Jung HE; Lee D; Lee HK; Lee JO; Park BS; Yoon TY; Kim HM
    Immunity; 2017 Jan; 46(1):38-50. PubMed ID: 27986454
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes.
    Heumann D; Gallay P; Barras C; Zaech P; Ulevitch RJ; Tobias PS; Glauser MP; Baumgartner JD
    J Immunol; 1992 Jun; 148(11):3505-12. PubMed ID: 1375247
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multiple receptors for endotoxin.
    Wright SD
    Curr Opin Immunol; 1991 Feb; 3(1):83-90. PubMed ID: 1711327
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Toll-like receptor 4 functions intracellularly in human coronary artery endothelial cells: roles of LBP and sCD14 in mediating LPS responses.
    Dunzendorfer S; Lee HK; Soldau K; Tobias PS
    FASEB J; 2004 Jul; 18(10):1117-9. PubMed ID: 15132988
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Involvement of CD14 and beta2-integrins in activating cells with soluble and particulate lipopolysaccharides and mannuronic acid polymers.
    Flo TH; Ryan L; Kilaas L; Skjâk-Braek G; Ingalls RR; Sundan A; Golenbock DT; Espevik T
    Infect Immun; 2000 Dec; 68(12):6770-6. PubMed ID: 11083794
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human monocytes lacking the membrane-bound form of the bacterial lipopolysaccharide (LPS) receptor CD14 can mount an LPS-induced oxidative burst response mediated by a soluble form of CD14.
    Schütt C; Schilling T; Grunwald U; Stelter F; Witt S; Krüger C; Jack RS
    Res Immunol; 1995; 146(6):339-50. PubMed ID: 8719658
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cell-free pool of CD14 mediates activation of transcription factor NF-kappa B by lipopolysaccharide in human endothelial cells.
    Read MA; Cordle SR; Veach RA; Carlisle CD; Hawiger J
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):9887-91. PubMed ID: 7694295
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Lipopolysaccharide binding protein enhances intratracheally administrated lipopolysaccharide-induced acute lung inflammation via a CD14 receptor].
    Ishii Y; Kitamura S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Dec; 30 Suppl():225-31. PubMed ID: 1284855
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stimulation of macrophages and neutrophils by complexes of lipopolysaccharide and soluble CD14.
    Hailman E; Vasselon T; Kelley M; Busse LA; Hu MC; Lichenstein HS; Detmers PA; Wright SD
    J Immunol; 1996 Jun; 156(11):4384-90. PubMed ID: 8666811
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lipopolysaccharide-induced stimulation of CD11b/CD18 expression on neutrophils. Evidence of specific receptor-based response and inhibition by lipid A-based antagonists.
    Lynn WA; Raetz CR; Qureshi N; Golenbock DT
    J Immunol; 1991 Nov; 147(9):3072-9. PubMed ID: 1717586
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Monoclonal antibodies to murine lipopolysaccharide (LPS)-binding protein (LBP) protect mice from lethal endotoxemia by blocking either the binding of LPS to LBP or the presentation of LPS/LBP complexes to CD14.
    Le Roy D; Di Padova F; Tees R; Lengacher S; Landmann R; Glauser MP; Calandra T; Heumann D
    J Immunol; 1999 Jun; 162(12):7454-60. PubMed ID: 10358200
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Membrane-anchored forms of lipopolysaccharide (LPS)-binding protein do not mediate cellular responses to LPS independently of CD14.
    Tapping RI; Orr SL; Lawson EM; Soldau K; Tobias PS
    J Immunol; 1999 May; 162(9):5483-9. PubMed ID: 10228028
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Moesin: a potential LPS receptor on human monocytes.
    Amar S; Oyaisu K; Li L; Van Dyke T
    J Endotoxin Res; 2001; 7(4):281-6. PubMed ID: 11717582
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endotoxin-mediated endothelial cell injury and activation: role of soluble CD14.
    Arditi M; Zhou J; Dorio R; Rong GW; Goyert SM; Kim KS
    Infect Immun; 1993 Aug; 61(8):3149-56. PubMed ID: 7687581
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lipopolysaccharide (LPS) binding protein opsonizes LPS-bearing particles for recognition by a novel receptor on macrophages.
    Wright SD; Tobias PS; Ulevitch RJ; Ramos RA
    J Exp Med; 1989 Oct; 170(4):1231-41. PubMed ID: 2477488
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lipopolysaccharide stimulates HepG2 human hepatoma cells in the presence of lipopolysaccharide-binding protein via CD14.
    Nanbo A; Nishimura H; Muta T; Nagasawa S
    Eur J Biochem; 1999 Feb; 260(1):183-91. PubMed ID: 10091598
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dynamic lipopolysaccharide transfer cascade to TLR4/MD2 complex via LBP and CD14.
    Kim SJ; Kim HM
    BMB Rep; 2017 Feb; 50(2):55-57. PubMed ID: 28115037
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neutrophil CD14: biochemical properties and role in the secretion of tumor necrosis factor-alpha in response to lipopolysaccharide.
    Haziot A; Tsuberi BZ; Goyert SM
    J Immunol; 1993 Jun; 150(12):5556-65. PubMed ID: 7685797
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An analogue of lipid A and LPS from Rhodobacter sphaeroides inhibits neutrophil responses to LPS by blocking receptor recognition of LPS and by depleting LPS-binding protein in plasma.
    Aida Y; Kusumoto K; Nakatomi K; Takada H; Pabst MJ; Maeda K
    J Leukoc Biol; 1995 Dec; 58(6):675-82. PubMed ID: 7499965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.